AAAAAA

   
Results: 1-25 | 26-28
Results: 1-25/28
EFFECT OF PLASMA POOLING ON THE INTERNATIONAL-SENSITIVITY-INDEX OF PROTHROMBIN TIME SYSTEMS
Authors: VANDENBESSELAAR AMHP WITTEVEEN E SCHAEFERVANMANSFELD H VANRIJN C VANDERMEER FJM
Citation: Amhp. Vandenbesselaar et al., EFFECT OF PLASMA POOLING ON THE INTERNATIONAL-SENSITIVITY-INDEX OF PROTHROMBIN TIME SYSTEMS, Blood coagulation & fibrinolysis, 9(7), 1998, pp. 645-651
SUPERIOR SAGITTAL SINUS THROMBOSIS IN A PATIENT HETEROZYGOUS FOR THE NOVEL 20210-A ALLELE OF THE PROTHROMBIN GENE
Authors: BLOEM BR VANPUTTEN MJAM VANDERMEER FJM VANHILTEN JJ BERTINA RM
Citation: Br. Bloem et al., SUPERIOR SAGITTAL SINUS THROMBOSIS IN A PATIENT HETEROZYGOUS FOR THE NOVEL 20210-A ALLELE OF THE PROTHROMBIN GENE, Thrombosis and haemostasis, 79(1), 1998, pp. 235-235
SUCCESSFUL EXCISION OF A PSEUDOTUMOR IN A CONGENITALLY FACTOR-V DEFICIENT PATIENT
Authors: TANIS BC VANDERMEER FJM BLOEM RM VLASVELD LT
Citation: Bc. Tanis et al., SUCCESSFUL EXCISION OF A PSEUDOTUMOR IN A CONGENITALLY FACTOR-V DEFICIENT PATIENT, British Journal of Haematology, 100(2), 1998, pp. 380-382
DANAPAROID SODIUM LOWERS PROTEINURIA IN DIABETIC NEPHROPATHY
Authors: VANDERPIJL JW VANDERWOUDE FJ GEELHOEDDUIJVESTIJN PHLM FROLICH M VANDERMEER FJM LEMKES HPJ VANES LA
Citation: Jw. Vanderpijl et al., DANAPAROID SODIUM LOWERS PROTEINURIA IN DIABETIC NEPHROPATHY, Journal of the American Society of Nephrology, 8(3), 1997, pp. 456-462
PATIENT COMPLIANCE IN ORAL ANTICOAGULANT-THERAPY (OAT)
Authors: VANDERMEER FJM BRIET E VANDENBROUCKE JP SRAMEK DI VERSLUIJS HPM ROSENDAAL FR
Citation: Fjm. Vandermeer et al., PATIENT COMPLIANCE IN ORAL ANTICOAGULANT-THERAPY (OAT), Thrombosis and haemostasis, 1997, pp. 2384-2384
CHARACTERIZATION OF INHIBITORS IN 2 PATIENTS WITH ACQUIRED HEMOPHILIA-A
Authors: VANDENBRINK EN TURENHOUT EAM BOSCH LJ VANDERMEER FJM FIJNVANDRAAT K TURKSTRA F KOOPMAN MMW VOORBERG J
Citation: En. Vandenbrink et al., CHARACTERIZATION OF INHIBITORS IN 2 PATIENTS WITH ACQUIRED HEMOPHILIA-A, Thrombosis and haemostasis, 1997, pp. 2649-2649
THE OPTIMAL INTENSITY OF ORAL ANTICOAGULANT TREATMENT IN THE PREVENTION OF ARTERIAL THROMBOEMBOLISM
Authors: TORN M ROSENDAAL FR BOLLEN ELEM VANDERWALL EE VANDERMEER FJM
Citation: M. Torn et al., THE OPTIMAL INTENSITY OF ORAL ANTICOAGULANT TREATMENT IN THE PREVENTION OF ARTERIAL THROMBOEMBOLISM, Thrombosis and haemostasis, 1997, pp. 2803-2803
THE LEIDEN THROMBOPHILIA STUDY (LETS)
Authors: VANDERMEER FJM KOSTER T VANDENBROUCKE JP BRIET E ROSENDAAL FR
Citation: Fjm. Vandermeer et al., THE LEIDEN THROMBOPHILIA STUDY (LETS), Thrombosis and haemostasis, 78(1), 1997, pp. 631-635
MANAGEMENT OF VENOUS THROMBOEMBOLISM
Authors: ROSENDAAL FR VANDERMEER FJM VANDENBROUCKE JP
Citation: Fr. Rosendaal et al., MANAGEMENT OF VENOUS THROMBOEMBOLISM, The New England journal of medicine, 336(21), 1997, pp. 1528-1529
THE ROLE OF COMPLIANCE AS A CAUSE OF INSTABILITY IN ORAL ANTICOAGULANT-THERAPY
Authors: VANDERMEER FJM BRIET E VANDENBROUCKE JP SRAMEK DI VERSLUIJS MHPM ROSENDAAL FR
Citation: Fjm. Vandermeer et al., THE ROLE OF COMPLIANCE AS A CAUSE OF INSTABILITY IN ORAL ANTICOAGULANT-THERAPY, British Journal of Haematology, 98(4), 1997, pp. 893-900
NO INDICATION FOR APTT SCREENING IN PATIENTS ON ORAL ANTICOAGULANT-THERAPY
Authors: VANDERMEER FJM BROEKSEMASLOT FJ KOELEWIJNVANDEUREN M ROSENDAAL FR
Citation: Fjm. Vandermeer et al., NO INDICATION FOR APTT SCREENING IN PATIENTS ON ORAL ANTICOAGULANT-THERAPY, Blood, 90(10), 1997, pp. 3269-3269
FACTOR-V LEIDEN - SHOULD WE SCREEN ORAL-CONTRACEPTIVE USERS AND PREGNANT-WOMEN
Authors: VANDENBROUCKE JP VANDERMEER FJM HELMERHORST FM ROSENDAAL FR
Citation: Jp. Vandenbroucke et al., FACTOR-V LEIDEN - SHOULD WE SCREEN ORAL-CONTRACEPTIVE USERS AND PREGNANT-WOMEN, BMJ. British medical journal, 313(7065), 1996, pp. 1127-1130
ASSESSMENT OF A BLEEDING RISK INDEX IN 2 COHORTS OF PATIENTS TREATED WITH ORAL ANTICOAGULANTS
Authors: VANDERMEER FJM ROSENDAAL FR VANDENBROUCKE JP BRIET E
Citation: Fjm. Vandermeer et al., ASSESSMENT OF A BLEEDING RISK INDEX IN 2 COHORTS OF PATIENTS TREATED WITH ORAL ANTICOAGULANTS, Thrombosis and haemostasis, 76(1), 1996, pp. 12-16
MONITORING HEPARIN TREATMENT WITH THE APTT - THE EFFECT OF METHODOLOGICAL CHANGES ON THE APTT
Authors: KRULDER JWM VANDERMEER FJM BRIET E MEINDERS AE
Citation: Jwm. Krulder et al., MONITORING HEPARIN TREATMENT WITH THE APTT - THE EFFECT OF METHODOLOGICAL CHANGES ON THE APTT, Netherlands journal of medicine, 49(1), 1996, pp. 13-18
INCREASED FETAL LOSS IN WOMEN WITH HERITABLE THROMBOPHILIA
Authors: PRESTON FE ROSENDAAL FR WALKER ID BRIET E BERNTORP E CONARD J FONTCUBERTA J MAKRIS M MARIANI G NOTEBOOM W PABINGER I LEGNANI C SCHARRER I SCHULMAN S VANDERMEER FJM
Citation: Fe. Preston et al., INCREASED FETAL LOSS IN WOMEN WITH HERITABLE THROMBOPHILIA, Lancet, 348(9032), 1996, pp. 913-916
RESPONSE OF THE ACTIVATED PARTIAL THROMBOPLASTIN TIME (APTT) TO HEPARIN IS INFLUENCED BY COAGULOMETERS
Authors: VANDENBESSELAAR AMHP MEEUWISSEBRAUN J STREBUS A SCHAEFERVANMANSFELD H WITTEVEEN E VANDERMEER FJM
Citation: Amhp. Vandenbesselaar et al., RESPONSE OF THE ACTIVATED PARTIAL THROMBOPLASTIN TIME (APTT) TO HEPARIN IS INFLUENCED BY COAGULOMETERS, Thrombosis and haemostasis, 74(5), 1995, pp. 1383-1384
THE OPTIMAL INTENSITY OF ANTICOAGULANT-THERAPY IN PATIENTS WITH MECHANICAL HEART-VALVE PROSTHESES
Authors: CANNEGIETER SC ROSENDAAL FR WINTZEN AR VANDERMEER FJM VANDENBROUCKE JP BRIET E
Citation: Sc. Cannegieter et al., THE OPTIMAL INTENSITY OF ANTICOAGULANT-THERAPY IN PATIENTS WITH MECHANICAL HEART-VALVE PROSTHESES, Thrombosis and haemostasis, 73(6), 1995, pp. 1116-1116
OPTIMAL ORAL ANTICOAGULANT-THERAPY IN PATIENTS WITH MECHANICAL HEART-VALVES
Authors: CANNEGIETER SC ROSENDAAL FR WINTZEN AR VANDERMEER FJM VANDENBROUCKE JP BRIET E
Citation: Sc. Cannegieter et al., OPTIMAL ORAL ANTICOAGULANT-THERAPY IN PATIENTS WITH MECHANICAL HEART-VALVES, The New England journal of medicine, 333(1), 1995, pp. 11-17
PROTEIN-C DEFICIENCY IN A CONTROLLED SERIES OF UNSELECTED OUTPATIENTS- AN INFREQUENT BUT CLEAR RISK FACTOR FOR VENOUS THROMBOSIS (LEIDEN THROMBOPHILIA STUDY)
Authors: KOSTER T ROSENDAAL FR BRIET E VANDERMEER FJM COLLY LP TRIENEKENS PH POORT SR REITSMA PH VANDENBROUCKE JP
Citation: T. Koster et al., PROTEIN-C DEFICIENCY IN A CONTROLLED SERIES OF UNSELECTED OUTPATIENTS- AN INFREQUENT BUT CLEAR RISK FACTOR FOR VENOUS THROMBOSIS (LEIDEN THROMBOPHILIA STUDY), Blood, 85(10), 1995, pp. 2756-2761
DIURNAL CHANGES IN HEPARIN EFFECT DURING CONTINUOUS CONSTANT-RATE INFUSION - A STUDY IN 9 PATIENTS WITH VENOUS THROMBOEMBOLISM
Authors: KRULDER JWM VANDENBESSELAAR AMHP VANDERMEER FJM MEINDERS AE BRIET E
Citation: Jwm. Krulder et al., DIURNAL CHANGES IN HEPARIN EFFECT DURING CONTINUOUS CONSTANT-RATE INFUSION - A STUDY IN 9 PATIENTS WITH VENOUS THROMBOEMBOLISM, Journal of internal medicine, 235(5), 1994, pp. 411-417
ASSESSMENT OF THERAPEUTIC QUALITY-CONTROL IN A LONG-TERM ANTICOAGULANT TRIAL IN POSTMYOCARDIAL INFARCTION PATIENTS
Authors: AZAR AJ DECKERS JW ROSENDAAL FR VANBERGEN PFMM VANDERMEER FJM JONKER JJC BRIET E
Citation: Aj. Azar et al., ASSESSMENT OF THERAPEUTIC QUALITY-CONTROL IN A LONG-TERM ANTICOAGULANT TRIAL IN POSTMYOCARDIAL INFARCTION PATIENTS, Thrombosis and haemostasis, 72(3), 1994, pp. 347-351
EFFECT OF LONG-TERM ORAL ANTICOAGULANT TREATMENT ON MORTALITY AND CARDIOVASCULAR MORBIDITY AFTER MYOCARDIAL-INFARCTION
Authors: JONKER JJC VANBERGEN PFMM VANDERMEER FJM AZAR AJ MEETER K DECKERS JW COLLY LP TIJSSEN JGP VANAKEN WG DUNNING AJ HOFMAN A HUGENHOLTZ PG VANDERKOOIJ S LOELIGER EA LUBSEN J MEADE TW VANDERMEER J MIETTINEN OS MITCHELL JRA MUSTARD JF PIETERS JJL VANSTRIK R VERHEUGT FWA VERSTRAETE M VIERSMA JW VANZWIETEN PA VANES GA VANSTRIK P VANZWIETEN PA BECKER AE VANDEBURGH PH DEGRAEFF JJ KOUDSTAAL PJ MOLHOEK GP DENEELING A DENOTTOLANDER GJ VANREES C WINTZEN AR ADMIRAAL J ANTHEUNISSEN IM BEINEMA MJ VANBEUSEKOM WI BOLWEGWAAGE MM BREUKINKENGBERS WGM BROEKMANS AW CHIN H VANDAM FE VANDOMBURG RT GERRITSDRABBE CW VANGEESTDAALDEROP J GEVENBOERE LM HANNIVOORT EJW HILLEN PH HEERE FJ HOLDRINET AC JELETICHBASTIAANSE A KIERS GJ KOUSEMAKER AC VANMEEGEN E PIERSMA G ROMMENS CAW SCHAAP RC VANDERVEUR E VRIESGOLDSCHMEDING J MEULENBELT F VANDERBREDA BM DUCHATEAU AMJA ENGELBERTS P BRENNINKMEYER VJ DAGNEAUX PGLCK VOS T VERMEIJ P BRANDENBURG HCR DUIJNE C GRAATSMA BH LENDERINK AW RUTTEN JJMH HARTING J SMITH TJ VANDERVEEN D VANDERBERGH D DIJKSHOORN A EIGENRAM P DEJONG JD KENSENHUIS IM MAHLER CCE VANDERSMAN AJ VISSER HC WIELDERS L DEBEER YAJ SPEELMAN M OEI S
Citation: Jjc. Jonker et al., EFFECT OF LONG-TERM ORAL ANTICOAGULANT TREATMENT ON MORTALITY AND CARDIOVASCULAR MORBIDITY AFTER MYOCARDIAL-INFARCTION, Lancet, 343(8896), 1994, pp. 499-503
WARFARIN AND ASPIRIN AFTER HEART-VALVE REPLACEMENT
Authors: CANNEGIETER SC VANDERMEER FJM BRIET R ROSENDAAL FR
Citation: Sc. Cannegieter et al., WARFARIN AND ASPIRIN AFTER HEART-VALVE REPLACEMENT, The New England journal of medicine, 330(7), 1994, pp. 507-508
THE FAMILY HISTORY AND INHERITED THROMBOPHILIA
Authors: BRIET E VANDERMEER FJM ROSENDAAL FR HOUWINGDUISTERMAAT JJ VANHOUWELINGEN HC
Citation: E. Briet et al., THE FAMILY HISTORY AND INHERITED THROMBOPHILIA, British Journal of Haematology, 87(2), 1994, pp. 348-352
PHARMACOKINETICS OF SARUPLASE, A RECOMBINANT UNGLYCOSYLATED HUMAN SINGLE-CHAIN UROKINASE-TYPE PLASMINOGEN-ACTIVATOR AND ITS EFFECTS ON FIBRINOLYTIC AND HEMOSTATIC PARAMETERS IN HEALTHY MALE-SUBJECTS
Authors: DEBOER A KLUFT C GERLOFF J DOOIJEWAARD G GUNZLER WA BEIER H VANDERMEER FJM COHEN AF
Citation: A. Deboer et al., PHARMACOKINETICS OF SARUPLASE, A RECOMBINANT UNGLYCOSYLATED HUMAN SINGLE-CHAIN UROKINASE-TYPE PLASMINOGEN-ACTIVATOR AND ITS EFFECTS ON FIBRINOLYTIC AND HEMOSTATIC PARAMETERS IN HEALTHY MALE-SUBJECTS, Thrombosis and haemostasis, 70(2), 1993, pp. 320-325
Risultati: 1-25 | 26-28